Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.

Biotechnology

Education

Myeloid Therapeutics

Myeloid Therapeutics' headquarters in Cambridge, MA, United States

Daniel Getts

Robert Hofmeister

Matthew Maurer

Curtis Demick

Jerome Chal

Tracy Ducott-Moroney

Darren Braccia

Ronald Vale

Thomas Cahill

Alberto Mantovani

Elaine Jones

Siddhartha Mukherjee

Miriam Merad

Siamon Gordon

Brett Kaplan

Yuxiao Wang

Michael Dee Gunn

Nick King

Owen A. O'Connor

Michael Lin

Cameron Turtle

Steven M. Horwitz

Stanley Frankel

Mark Velleca

Clay B. Thorp

The Research and Development team at Myeloid Therapeutics is dedicated to advancing innovative therapies targeting myeloid cells to combat cancer and other diseases. This multidisciplinary team, comprised of scientists and engineers specializing in areas such as cell engineering, RNA science, and antibody discovery, collaborates to develop and optimize experimental approaches, analyze data, and translate research findings into effective clinical applications. Their cutting-edge work integrates biological insights with advanced technologies to propel the company’s mission of enhancing patient outcomes.

Research and Development

The Advisory and Strategic Roles team at Myeloid Therapeutics comprises experienced leaders and experts who provide strategic guidance and insights to shape the company's vision and growth. They leverage their extensive industry knowledge and networks to drive innovative approaches in immunology and foster collaborations that enhance the development of therapies targeting myeloid cells for cancer treatment.

Advisory and Strategic Roles

The Leadership Team at Myeloid Therapeutics drives the strategic vision and operational excellence of the company. Comprised of experienced founders and executives, the team focuses on fostering innovation in immunology research, forging partnerships, and ensuring effective resource allocation to accelerate the development of therapies that leverage myeloid cells in the fight against cancer and other diseases.

Leadership Team

The Finance and Accounting team at Myeloid Therapeutics manages the company’s financial health by overseeing budgeting, forecasting, and financial reporting. They ensure compliance with regulatory standards, optimize financial strategies to support the company’s growth in immunology research, and provide critical insights for strategic decision-making. Their work is essential in facilitating the financial resources needed to advance innovative therapies targeting cancer and other diseases.

Finance and Accounting

Myeloid Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Advisory and Strategic Roles

Leadership Team

Finance and Accounting

Offices

Myeloid Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Advisory and Strategic Roles

Leadership Team

Finance and Accounting

Offices

Related companies